Edwards Receives CE Mark For Hypotension Probability Indicator
MILAN, Oct. 3, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it received CE Mark for its Acumen Hypotension Probability Indicator (HPI), a breakthrough technology that alerts clinicians to potential hypotension, or abnormally low blood pressure, in their surgical and critical care patients before it occurs. HPI is only compatible with Edwards' minimally invasive, hemodynamic monitoring solutions. "Studies have shown that even short durations of hypotension can be harmful to patients," said Monty Mythen, the Smiths Medical Professor of Anaesthesia and Critical Care at University College London. "A first-of-its-kind technology that enables clinicians to detect and address potentially developing hypotensive events is a major advance in patient care."HPI comprises three elements:
- The hypotension probability parameter, which indicates the possibility of a hypotensive event using machine learning techniques developed from more than 20,000 past patient events;
- An alarm that alerts clinicians when hypotension probability exceeds an upper threshold;
- And a secondary screen that visually links blood pressure to hemodynamic flow parameters, such as cardiac output and contractility.